Deep Track Capital’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.6M Buy
+1,323,986
New +$18.3M 0.27% 58

Other funds holding DSGN

Deep Track Capital's DSGN Position: Q3 2026 in Review

Deep Track Capital opened a new position in Design Therapeutics (DSGN) in Q3 2026: 1,323,986 shares worth $16.6M. The stake represents 0.27% of the portfolio and ranks #58 among its holdings.

96 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.

  • Deep Track Capital held 1,323,986 shares of Design Therapeutics worth $16.6M as of Q3 2026.
  • Design Therapeutics was a new Deep Track Capital position in Q3 2026.
  • Design Therapeutics made up 0.27% of Deep Track Capital's portfolio in Q3 2026, its #58 holding.
  • 96 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.

Based on Deep Track Capital's 13F filing for Q3 2026, filed 16 Nov 2026.